I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After Radiotherapy

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2026

Conditions
BrachytherapyNon-small Cell Lung Cancer
Interventions
RADIATION

3D-printing Template-assisted CT-guided I-125 Seeds Implantation

(1) positioning and preoperative plan design;(2) 3D printing template design and production;(3) reset and seeds implantation;(4) intraoperative optimization;Postoperative dose verification.Dosimetric parameters include: dose D90 and D100 reaching a certain percentage target volume; Target volume V100, V150 and V200 reaching a certain percentage of prescribed dose;And the dose of organs at risk: Dmean, D2cc, d0.5cc, d0.1cc. Regular follow-up was conducted after treatment.

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER